Drug Search Results

Dianicline

Alternative Names: dianicline
Latest Update: 2024-05-08
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: nAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dianicline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Smoking Cessation|Tobacco Use Disorder

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
AMERIDIAN	P3	Completed	Smoking Cessation\|Tobacco Use Disorder	2007-09-01
EURODIAN	P3	Completed	Tobacco Use Disorder	2007-06-01

Recent News Events

Date	Type	Title
05/08/2024	PubMed	Pseudoaromaticity-driven, transition metal detection by squaraine-derived enol phosphonium ylide chemodosimeters.
05/06/2024	PubMed	Cd2+-Specific Fluorescence Response of Methoxy-Substituted N,N-Bis(2-quinolylmethyl)-2-methoxyaniline Derivatives.
11/23/2023	PubMed	Synthesis, Characterization, and Proton Conductivity of Muconic Acid-Based Polyamides Bearing Sulfonated Moieties.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions